Publication | Closed Access

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial

VaccinationVaccine SafetyMonovalent Varicella VaccineVaccine DevelopmentPhase 3Infection ControlMedicineVaccine ResearchEpidemiologyCombined Measles-mumps-rubella-varicella Vaccine